NBR reduces source tax on cancer drug

BSS
Published On: 04 Mar 2025, 00:02

DHAKA, Mar 3, 2025 (BSS) - National Board of Revenue (NBR) has reduced the existing source tax on the import of raw materials used to manufacture cancer medicines.

Source tax has been reduced from 5% to 2% to make cancer treatment more accessible in the country.

To this end, NBR issued an SRO on Sunday. 

Cancer treatment facilities in Bangladesh are limited and many are forced to seek advanced treatment abroad.

Talking to BSS, a senior official of NBR said, the interim government has taken several initiatives to make treatment for cancer and other complex diseases locally available.

  • Latest
  • Most Viewed
Uninterrupted supply of goods key to market management: Bashir 
Mourning Nepalis hope protest deaths will bring change
CA congratulates new Nepalese PM 
Moheshkhali-Matarbari seaport to boost Bangladesh's fish export growth
Myanmar air strike kills at least 19 high school students: armed group
Occupational health and safety management training begins at KU
A day-long baseball training camp held in Chattogram 
$234b plundered during 15-yr Hasina regime: FT
1230th RSSP literary meeting held in Rangpur
Twelve soldiers killed in Pakistani Taliban attack: officials
১০